Group One Trading, L.P. Akero Therapeutics, Inc. Call Options Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
275Shares Held
85.8MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$359 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$342 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$287 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$270 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$253 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.25B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...